Cyclic depsipeptides containing the structural element 3-amino-6-hydroxy-2-piperidone (AHP) (so-called cyanopeptolins) are widely distributed secondary metabolites in cyanobacteria. 1 The structural diversity of previously described compounds is large, but all can be considered inhibitors of serine proteases of crustaceans and mammals. 1 Although preferentially mammalian enzymes in the context of pharmacological research have been tested, the evolutionary primary target enzymes can be assumed to be those of aquatic invertebrates that are important grazers of these cyanobacteria.
1 Digestive serine proteases of these invertebrates are strongly inhibited 2 and could thus render the cyanobacteria unsuitable food for them.
The conserved feature of serine proteases in evolution allows these inhibitors to be successfully applied also against mammalian enzymes. Most of the AHP-containing compounds are active in the micromolar range, 1c but some fit so perfectly in the reaction center of mammalian serine proteases that nanomolar concentrations were shown to be sufficient for inhibition. 3 Co-crystallization experiments have been conducted to analyze in atomic detail the binding properties of such an inhibitor to the reaction center of mammalian trypsin. 4 While the inhibition of digestive serine proteases of various organisms is well established, on the acute toxicity of some of these congeners is not understood. Microcystilide A when applied intraperitoneally to mice induced convulsions and spasms but not death. 5 Cyanopeptolin SS isolated from a natural cyanobacterial bloom caused death of crustaceans 6 as did oscillapeptin J for Thamnocephalus platyurus. 7 While little is known about the toxicity of cyanopeptolins, the most studied cyanobacterial toxins are the microcystins, which exert their hepatotoxicity through protein phosphatase inhibition 8 and are produced by species of the genera Here we report on an extremely potent, picomolar trypsin inhibitor, cyanopeptolin 1020 (1), which also binds in the low nanomolar range to factor XIa and human kalllikrein. In addition, this compound exhibits acute toxic properties against the crustacean Thamnocephalus platyurus. In addition to several microcystins found in the producing strain, cyanopeptolin 1020 (1) constitutes a second toxic compound class, which thus provides supporting evidence for multiple toxin production in Cyanopeptolin 1020 (1)
Microcystis.
The 60% methanolic extract of the biomass of Microcystis aeruginosa UV-006 was fractionated and assayed against the sensitive freshwater crustacean Thamnocephalus platyurus for acute toxicity. Overall, more than 20 different compounds were present in these fractions, and out of totally 16 fractions, nine were found to display acute toxicity in this assay. Among these nine fractions, eight compounds were assigned as known or new microcystins ( The configuration of 1 was determined by hydrolysis and the enantiomers were separated following Marfey's method. This procedure established the configuration of 4 we docked cyanopeptolin 1020 into the active site of bovine trypsin (AutoDock 4.0). Additionally, we wanted to confirm the toxicity of cyanopeptolin 1020 (1) against the sensitive freshwater crustacean Thamnocephalus platyurus using the highly purified cyanopeptolin 1020 (1). T. platyurus serves as a benchmark organism for the evaluation of the ecotoxicological potential of natural products. 15 We have determined an LC 50 value of 8.8 M in the 24-h acute toxicity assay ( Figure S14 , supporting information oscillapeptin J, has been described of similar acute toxic activity. 7 It can be speculated that these toxic effects are related to the very potent serine protease inhibition as described above, in particular as the large family of trypsin-like proteases 17 are involved in many key processes related to the viability of organisms. More detailed toxicological studies on mammals are thus encouraged by this study.
In this note, we have reported the structure elucidation of cyanopeptolin 1020 (1) extracted from Microcystis aeruginosa UV-006, which inhibits trypsin in the picomolar range and factor XIa and kallikrein in the low nanomolar range. This compound was shown to be toxic to the freshwater crustacean T. platyurus, and its toxicity was determined to be comparable to commonly found microcystins, which Configuration of Ahp. The oxidation was realized according to the procedure developed by Itou et al. 18 Cyanopeptolin 1020 (1 , 0.1 mg, 0.1 mol) was oxidized in a solution (0.5 mL) of CrO 3 in AcOH (1 mg / mL) at room temperature for 2 hours.
The mixture was then applied onto a C 18 SPE cartridge conditioned with 10% MeOH.
After applying the mixture, the cartridge was first washed with H 2 O, and the material was eluted with MeOH. After evaporation of the MeOH the resulting oxidized material was hydrolyzed, derivatized and analyzed as described above. Only the Table S2 . The enzyme inhibition assays were carried out in using modified literature procedures. 19 The kinetic fluorescence measurements were realized with transparent microplates (Nunc) using a fluorescence microplate reader (Tecan infinite M1000) set at  em = 355 nm,  ex = 480 nm and measuring a datapoint every 30 seconds for 1 h. To obtain the initial reaction rate, linear regression was performed with Microsoft Excel. The enzymes were dissolved in a buffer containing 50 mM Tris-HCl pH 7.4, 100 mM NaCl, 10 mM MgCl 2 , 1 mM CaCl 2 , 0.1% BSA and 0.01% Triton X-100. To facilitate the dissolution of the substrates, 7.5% DMSO was added. The DMSO amended buffer was also used as blank. Optimal enzyme concentrations were determined by measuring kinetics with different enzyme concentration. The substrate solution (50 µL) was added to a mixture of 50 µL of the enzyme solution and 50 µL of the blank. The enzyme concentrations were assayed between 0.1 and 10 nM (final concentration). The optimal protease concentrations are listed in Table S2 . For the inhibition assays, a 35.0, CH 2 2.90, dd (13.9, 11.8) 1.80, dd (13.9, 3.7) Phe-1', Phe-2'/6' Phe-2'/6' Phe-3b 1' 136.5, C 2'/6' 129.2, CH 6.84, d (7. 3) Phe-3, Phe-2'/6', Phe-5' Phe-2, Phe-3a, Phe-3b, Ahp-4b,Ahp-2, CH 7.18, dd (7.3, 7. 3) Phe-2'/6', Phe-3'/5', Phe-4' Phe-2'/6', N-Me-Tyr-2'/6', N-Me-Tyr-3'/5' 4' 125.9, CH 7.14, d ( 
